KR19990033613A - Use of beta-glucogallin compounds as antioxidants and methods for their isolation and purification - Google Patents
Use of beta-glucogallin compounds as antioxidants and methods for their isolation and purification Download PDFInfo
- Publication number
- KR19990033613A KR19990033613A KR1019970055018A KR19970055018A KR19990033613A KR 19990033613 A KR19990033613 A KR 19990033613A KR 1019970055018 A KR1019970055018 A KR 1019970055018A KR 19970055018 A KR19970055018 A KR 19970055018A KR 19990033613 A KR19990033613 A KR 19990033613A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- beta
- methanol
- antioxidant
- present
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 25
- GDVRUDXLQBVIKP-HQHREHCSSA-N 1-O-galloyl-beta-D-glucose Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-HQHREHCSSA-N 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000000746 purification Methods 0.000 title claims description 4
- 238000002955 isolation Methods 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 65
- 239000000284 extract Substances 0.000 claims abstract description 43
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 229920000296 Glucogallin Polymers 0.000 claims abstract description 11
- GDVRUDXLQBVIKP-UHFFFAOYSA-N beta-D-glucogallin Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-UHFFFAOYSA-N 0.000 claims abstract description 11
- -1 beta glucogallin compound Chemical class 0.000 claims abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 51
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 28
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 23
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000003960 organic solvent Substances 0.000 claims description 12
- 239000000401 methanolic extract Substances 0.000 claims description 11
- 238000004440 column chromatography Methods 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000005227 gel permeation chromatography Methods 0.000 claims description 4
- 238000010898 silica gel chromatography Methods 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 235000020510 functional beverage Nutrition 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims 1
- 239000002021 butanolic extract Substances 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 abstract description 7
- 239000001301 oxygen Substances 0.000 abstract description 7
- 238000001727 in vivo Methods 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 description 20
- 239000002904 solvent Substances 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 239000002034 butanolic fraction Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 240000002234 Allium sativum Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 240000006066 Rosa rugosa Species 0.000 description 2
- 235000000659 Rosa rugosa Nutrition 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000061 acid fraction Substances 0.000 description 2
- 239000012223 aqueous fraction Substances 0.000 description 2
- 239000002036 chloroform fraction Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- 208000000187 Abnormal Reflex Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical group OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001766 catechin derivatives Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 206010020745 hyperreflexia Diseases 0.000 description 1
- 230000035859 hyperreflexia Effects 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 화학식 1로 표시되는 베타그루코갈린 화합물을 항산화제로 사용하는 용도 및 그의 분리·정제 방법에 관한 것으로서, 보다 상세하게는 해당화를 유기용매로 추출하여 항산화 활성을 가지는 해당화 추출물을 얻고 이로부터 베타그루코갈린 화합물을 분리·정제하는 방법에 관한 것이다.The present invention relates to a use of a beta glucogallin compound represented by the general formula (1) as an antioxidant, and a method of separating and purifying the same. More particularly, the present invention relates to a method for extracting a corresponding extract having an antioxidative activity And a method for separating and purifying a beta-glucogalline compound.
본 발명의 베타그루코갈린 화합물 및 해당화 추출물은 항산화 활성이 탁월하여 생체내 활성산소종을 조절하는 천연 항산화제로 그 이용이 기대된다.The beta-glucogallin compound and its extract of the present invention have excellent antioxidant activity and are expected to be used as a natural antioxidant for controlling active oxygen species in vivo.
Description
본 발명은 하기 화학식 1로 표시되는 베타그루코갈린(β-glucogallin) 화합물을 항산화제로 사용하는 새로운 용도 및 그의 제조방법에 관한 것이다.The present invention relates to a novel use of a beta-glucogallin compound represented by the following formula (1) as an antioxidant and a method for producing the same.
화학식 1Formula 1
보다 상세하게는, 본 발명은 해당화를 유기용매로 추출하여 항산화 활성을 가지는 해당화 추출물을 얻고 이로부터 베타그루코갈린 화합물을 분리·정제하는 방법에 관한 것으로서, 본 발명의 베타그루코갈린 화합물 및 해당화 추출물은 항산화 활성이 탁월하여 생체내 활성산소종을 조절하는 천연 항산화제로 그 이용이 기대된다.More particularly, the present invention relates to a method for isolating and purifying a beta glucogallgyline compound by extracting an appropriate extract having an antioxidative activity by extracting a corresponding compound with an organic solvent, The extract is expected to be used as a natural antioxidant to control active oxygen species in vivo because of its excellent antioxidant activity.
인간을 포함한 모든 호기성 생물체는 산소(O2)를 이용하여 에너지 대사를 진행하며 생존하고 있다. 그러나, 생체내 산소가 각종 물리적, 화학적, 생물학적인 스트레스를 받으면 수퍼옥사이드 음이온 라디칼(superoxide anion radical,.O2 -), 과산화수소(H2O2), 히드록시 라디칼(hydroxy radical,.OH) 등의 유해한 활성산소종(active oxygen species)으로 변하여 인체에 치명적인 생리적 장애를 일으키고 심할 경우는 질병을 유발하고 생명을 잃게 한다.All aerobic organisms, including humans, use oxygen (O 2 ) to metabolize energy and survive. However, in vivo oxygen, various physical, chemical, upon receiving the biological stress, superoxide anion radical (superoxide anion radical, O 2 - .), Hydrogen peroxide (H 2 O 2), hydroxyl radical (. Hydroxy radical, OH), etc. Of active oxygen species in the body, causing a deadly physiological disorder in the body, and in severe cases, causing disease and losing its life.
생체는 활성산소종을 제거하는 자기방어기구로서 항산화기구(antioxidative mechanism)를 발달시키면서 진화하여 왔다고 생각되지만, 조직의 방어능을 초월한 활성산소종의 발생은 단백질, DNA, 효소 및 T세포와 같은 면역계통의 인자를 손상시켜 각종 질환의 원인이 된다. 또한 활성산소종은 세포 생체막의 구성 성분인 불포화 지방산을 공격하여 과산화반응을 일으키고 이로 인해 생체내 축적된 과산화지질은 노화와 각종 질병을 유발하는 것으로 알려져 있다(Halliwell, B., Drugs, 42: 569, 1991; Fukuzawa, K. and Takaishi, Y., J. Act. Dxyg. Free Rad. 1: 55, 1990; Neuzil, J., Gebicki, J. M. and Stocker, R., Biochem. J. 293: 601, 1993; Sies, H., ed., Oxidative stress, 1985; Steinberg, D., et al., N. Engl. J. Med. 320: 915, 1989; 二木銳雄, フリ-ラジカルと 和韓藥, 1990).It is thought that the living body evolved by developing an antioxidative mechanism as a self-defense mechanism for removing reactive oxygen species, but the generation of reactive oxygen species beyond the protective ability of the tissue is caused by immune such as protein, DNA, enzyme and T cell It damages the factors of the system and causes various diseases. In addition, the reactive oxygen species attack the unsaturated fatty acid, which is a constituent of the cell membrane, and cause a peroxidation reaction. Thus, it is known that lipid peroxidation accumulated in vivo causes aging and various diseases (Halliwell, B., Drugs, 42: 569 J., Gebicki, JM and Stocker, R., Biochem., J. 293: 601, 1990. Neuzil, J., Gebicki, JM and Stocker, K. and Takaishi, Y., J. Act. Dxyg. Free Rad. 1993; Sies, H., ed., Oxidative stress, 1985; Steinberg, D., et al., N. Engl. J. Med. 320: 915, 1989; , 1990).
최근 노화와 성인병 질환의 원인이 활성산소종에 기인된 것이라는 학설이 인정됨에 따라 활성산소종를 조절할 수 있는 물질로 알려진 항산화제의 개발연구가 활발히 진행되어 수퍼옥사이드 디스뮤타아제(superoxide dismutase), 퍼옥시다아제(peroxidase), 카탈라아제(catalase), 글루타티온 퍼옥시다아제(glutathione peroxidase) 등의 항산화효소와 토코페롤(tocopherol), 아스코베이트(ascorbate), 카로테노이드 (carotenoid), 글루타티온(glutathione) 등의 천연물 유래의 저분자 항산화 물질에 대한 많은 연구가 이루어지고 있으며(Chang, S. S., et al., J. Food Sci. 42: 1102, 1977; Hammerschmidt, P. A. and Pratt, D. E., J. Food Sci. 43: 556, 1977; Pratt, D. E. and Watts, B. W., J. Food Sci. 29: 17, 1964), 2,6'-디-tert-부틸-4-히드록시 톨루엔(2,6'-di-tert-butyl-4-hydroxytoluene, BHT), 2,6'-디-tert-부틸-4-히드록시 아니졸(2,6-di-tert-butyl-4-hydroxyanisole, BHA) 등의 합성 항산화제가 많이 개발되어 의약품과 식품분야에서 이용되고 있다(Kitahara, K., et al., Chem. Pharm. Bull. 40: 2208, 1992; Hatano, T., Natural Medicines 49: 357, 1995; Masaki, H., et al., Biol. Pharm. Bull. 18: 162, 1995).Recently, research has been actively conducted on the development of antioxidants known as substances capable of regulating reactive oxygen species, as the theory that aging and diseases of adult diseases are caused by active oxygen species has been actively studied, and superoxide dismutase, peroxidase (antioxidant enzymes such as peroxidase, catalase and glutathione peroxidase) and low-molecular-weight antioxidants derived from natural products such as tocopherol, ascorbate, carotenoid and glutathione 42, 1102, 1977; Hammerschmidt, PA and Pratt, DE, J. Food Sci. 43: 556, 1977; Pratt, DE and 2,7'-di-tert-butyl-4-hydroxytoluene (BHT) , 2,6'-di-tert-butyl-4-hyd 40, 2208, 1992; Hatano, T., Natural Medicines 49 (1995), pp. : 357, 1995; Masaki, H., et al., Biol. Pharm. Bull.
그러나 합성 항산화제에 대한 소비자의 기피성향과 합성 항산화제가 대량으로 투여된 동물실험에서 발암성이 보고되고 있어(Branen, A. L., JAOCS 52: 59, 1975) 합성 항산화제의 사용이 점점 제한되고 있다. 이로 인하여 효력이 탁월하고 보다 안전한 새로운 천연 항산화제의 개발이 절실히 요구된다.However, the use of synthetic antioxidants has become increasingly limited due to the tendency of consumers to avoid synthetic antioxidants and the use of synthetic antioxidants in large-scale animal studies (Branen, A. L., JAOCS 52: 59, 1975). Therefore, it is urgently required to develop a new natural antioxidant which is excellent in efficacy and safer.
해당화는 장미과에 속하는 낙엽관목으로 동양에서는 정원수와 약용식물로 이용되고 있다. 중국에서는 건조시킨 꽃을 타박상, 풍비, 복중냉통(腹中冷痛) 및 부인의 월경과다(月經過多), 하리(下痢)의 치료 뿐만 아니라 차로써 이용되고 있으며(강소신의학원, 중약대사전, 4909, 1985), 일본에서는 꽃을 항설사, 지혈제(止血劑) (Shibata, K. ed., A cyclopedia of useful plant and plant products: Enlarged and revised edition, 612, 1957) 및 천연 착색료로 이용하기도 한다. 우리나라에서는 민간요법으로 지하부를 당뇨병치료제로 사용하고 있다.It is a deciduous shrub belonging to Rosaceae and is used as a garden and medicinal plant in the Orient. In China, dried flowers are used as tea as well as treatment of bruises, air intoxication, cold pain in the abdomen, and menstrual hyperreflexia and diarrhea of the lady (Jiangsu Shin school, 4909, 1985). In Japan, flowers are used as anti-diarrhea, hemostatic agents (Shibata, K. ed., A cyclopedia of useful plant and plant products: Enlarged and revised edition, 612, 1957) . In Korea, folk remedies use the underground as a treatment for diabetes.
박 등은 해당화를 대상으로 화학성분과 생리 활성물질을 보고하였으며(박 등, 생약학회지, 24: 319, 1993), 하시도코는 탄닌(tannin)류를 비롯하여 카테킨(catechin) 유도체, 플라보노이드(flavonoid), 터페노이드(terpenoid) 등 해당화가 생산하는 물질 및 대사산물을 발표한 바 있다(Hashidoko, Phytochemistry 43: 535, 1996).Hashimoto et al. Reported a chemical composition and a physiologically active substance in the corresponding tissues (Park et al., Journal of Pharmacopoeia, 24: 319, 1993), Hadadoko reported that tannins, catechin derivatives, flavonoids, , And terpenoid (Hashidoko, Phytochemistry 43: 535, 1996).
그러나 해당화를 대상으로 한 항산화 활성을 갖는 활성물질의 규명은 보고된 바 없다.However, there has been no report on the active substances having antioxidative activity against the subject.
이에 본 발명자들은 효력이 탁월하고 안전한 새로운 천연 항산화제를 개발하기 위하여 수십종의 약용식물을 대상으로 항산화 활성을 조사한 결과, 해당화(Rosa rugosa)를 유기용매로 추출한 해당화 추출물이 높은 항산화 활성을 보이는 것을 발견하고 이로부터 DPPH 자유 라디칼(free radical) 소거법(Choi, J. S., et al., Kor. J. Pharmacognosy 24: 299, 1993)에 의한 방법으로 항산화 활성을 가지는 물질을 분리하여 그 이화학적 특성을 조사한 결과 베타그루코갈린임을 확인함으로써 본 발명을 완성하였다.Accordingly, the inventors of the present invention have investigated antioxidative activity of dozens of medicinal plants in order to develop a new natural antioxidant which is excellent in efficacy and safety. As a result, it has been found that the extract obtained from the extract of Rosa rugosa with an organic solvent has a high antioxidative activity (Choi, JS, et al., Kor. J. Pharmacognosy 24: 299, 1993), and their physicochemical properties were investigated by separating the substances having antioxidative activity by the method of DPPH free radical scavenging The result was confirmed as beta-glucogallin, thereby completing the present invention.
본 발명은 베타그루코갈린 화합물을 항산화제로 사용하는 용도, 항산화 활성을 가지는 해당화 추출물 및 해당화 추출물로부터 베타그루코갈린 화합물을 분리·정제 방법을 제공하는 것을 목적으로 한다.The present invention aims to provide a use of a beta glucogalline compound as an antioxidant, a method for separating and purifying a beta glucogallgrin compound from a corresponding extract having an antioxidative activity and a corresponding extract.
도 1 은 해당화 추출물로부터 분리·정제된 베타그루코갈린 화합물의 질량분석 스펙트럼을 나타낸 것이고,FIG. 1 shows a mass spectrometry spectrum of a beta glucogallgyline compound isolated and purified from a corresponding extract,
도 2 는 해당화 추출물로부터 분리·정제된 베타그루코갈린 화합물의 수소 핵자기 공명 스펙트럼을 나타낸 것이고,2 shows the hydrogen nuclear magnetic resonance spectrum of the beta-glucogallgene compound isolated and purified from the corresponding extract,
도 3 은 해당화 추출물로부터 분리·정제된 베타그루코갈린 화합물의 탄소 핵자기 공명 스펙트럼을 나타낸 것이다.FIG. 3 is a carbon nuclear magnetic resonance spectrum of a beta-glucogallgene compound isolated and purified from a corresponding extract.
상기 목적을 달성하기 위하여, 본 발명은 하기 화학식 1로 표시되는 베타그루코갈린 화합물을 항산화제로 사용하는 용도를 제공한다.In order to achieve the above object, the present invention provides a use of a beta glucogallgine compound represented by the following general formula (1) as an antioxidant.
화학식 1Formula 1
또한 본 발명은 해당화를 저급 알코올로 추출하여 얻은 항산화 활성을 가지는 해당화 추출물을 제공한다.In addition, the present invention provides an extract of Aloe vera with an antioxidative activity obtained by extracting a corresponding algae with a lower alcohol.
또한, 본 발명은 해당화 지상부를 메탄올로 추출한 다음 유기용매인 헥산, 클로로포름, 에틸아세테이트 및 부탄올 등의 유기용매를 가하여 다시 추출한 항산화 활성을 가지는 해당화 추출물을 제공한다.In addition, the present invention provides an extract of the present invention having an antioxidative activity which is extracted with methanol and then extracted again with an organic solvent such as an organic solvent such as hexane, chloroform, ethyl acetate and butanol.
또한, 본 발명은 해당화 지상부를 메탄올에 침지시켜 반복 추출하고 농축하여 메탄올 추출물을 얻은 다음 이를 증류수에 현탁시키고 헥산, 클로로포름, 에틸아세테이트 및 부탄올 등의 유기용매를 차례대로 가하여 그에 해당되는 용매 추출분획을 얻는 항산화 활성을 가지는 해당화 추출물의 제조방법을 제공한다.The present invention also relates to a method for producing a methanol extract, which comprises immersing the above-ground top part in methanol, repeatedly extracting and concentrating the methanol extract, suspending the extract in distilled water, adding an organic solvent such as hexane, chloroform, ethyl acetate and butanol sequentially, And a method for producing the extract having the antioxidant activity.
또한, 본 발명은 상기 해당화 추출물로부터 실리카겔 크로마토그라피, ODS 칼람 크로마토그라피, GPC 칼람 크로마토그라피를 수행하여 베타그루코갈린을 분리·정제하는 방법을 제공한다.In addition, the present invention provides a method for separating and purifying beta glucogallin by performing silica gel chromatography, ODS column chromatography, and GPC column chromatography from the above extract.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 항산화 활성을 가지는 해당화 추출물을 제공한다.The present invention provides a corresponding extract having antioxidative activity.
우선 본 발명은 해당화를 저급 알코올에 침지시켜 반복 추출하여 항산화 활성을 가지는 해당화의 알코올 분획을 얻는다. 이 때 알코올로는 메탄올을 사용하고 해당화 지상부로는 줄기, 잎, 이들의 건체 및 차로 이용되고 남은 잔사 등을 사용하는 것이 바람직하고 잎을 사용하는 것은 더욱 바람직하다.First, the present invention is to immerse an animal in a lower alcohol and repeatedly extract it to obtain an alcohol fraction of an animal having an antioxidative activity. In this case, it is preferable to use methanol as the alcohol, and to use the stem, the leaves, the dryness and the residue of the leaves, and the remaining residue as the applicable ground, and it is more preferable to use the leaves.
또한 본 발명은 해당화 지상부를 상기 과정으로 메탄올로 추출한 다음 다시 유기용매를 사용하여 얻은 항산화 활성을 가지는 해당화 추출물을 제공한다. 이 때 유기용매로는 저급알코올을 포함하여 헥산, 에틸아세테이트, 클로로포름 또는 부탄올 등을 포함한다.In addition, the present invention provides an extract having the antioxidative activity obtained by extracting the above-ground part with methanol and then using an organic solvent. The organic solvent includes a lower alcohol such as hexane, ethyl acetate, chloroform or butanol.
또한, 본 발명은 해당화 지상부를 메탄올로 추출한 다음 유기용매를 사용하여 다시 추출하는 항산화 활성을 가지는 해당화 추출물의 제조방법을 제공한다.In addition, the present invention provides a method for preparing a corresponding extract having an antioxidative activity of extracting a corresponding top part with methanol and then extracting it again with an organic solvent.
본 발명은 해당화의 지상부를 메탄올로 추출하여 농축한 메탄올 추출물을 이용하여 유기용매로 분획함으로 항산화 활성이 우수한 해당화의 부탄올 분획 등을 제조한다.In accordance with the present invention, a methanol extract of methanol and a concentrated methanol extract are used to fractionate an organic solvent to produce a butanol fraction, etc., having excellent antioxidative activity.
구체적으로, 본 발명은 충청남도 천리포 해변에서 채취한 해당화의 마른잎을 메탄올에 잠길 정도로 넣고 1 - 5회 반복하여 추출한 다음 이를 다시 농축 건조시켜 메탄올 추출물을 제조한다. 또한, 본 발명은 상기에서 얻은 메탄올 추출물을 증류수에 현탁시키고 동량의 용매를 첨가하여 각종 용매에 이행하는 분획을 모아 감압농축하여 다양한 용매 추출분획을 제조한다.Specifically, the present invention extracts dried leaves of Chrysanthemum japonica collected from Chunglipo beach, Chungcheongnam-do province, to the extent that it is immersed in methanol, repeats the extraction one to five times, and then concentrates and drying it to produce a methanol extract. In addition, in the present invention, the methanol extract obtained above is suspended in distilled water, and an equal amount of a solvent is added to collect the fractions to be transferred to various solvents and concentrate under reduced pressure to prepare various solvent-extracted fractions.
실제로 본 발명은 헥산, 클로로포름, 에틸아세테이트, 부탄올 등을 차례대로 사용하여 해당화의 헥산 추출분획, 에틸아세테이트 추출분획, 부탄올 추출분획 및 물 추출분획 등을 제조하였다.Actually, the present invention uses hexane, chloroform, ethyl acetate, butanol, and the like in sequence to prepare hexane-extracted fraction, ethyl acetate-extracted fraction, butanol-extracted fraction and water-extracted fraction.
또한, 본 발명은 상기 해당화 추출물을 유효성분으로 하는 항산화 활성이 있는 약학적 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition having an antioxidative activity using the above extract as an active ingredient.
구체적으로 상기 약학적 조성물은 생체내 활성산소종을 조절하여 노화와 성인병 질환을 예방, 치료하는데 사용될 수 있다.Specifically, the pharmaceutical composition can be used for controlling active oxygen species in vivo to prevent and treat aging and geriatric diseases.
실제로 본 발명의 해당화 추출물을 이용하여 항산화 활성을 조사한 결과, 해당화 추출물은 조추출물인 상태에서도 강한 항산화 활성이 있고, 특히 헥산, 클로로포름 추출분획은 탁월한 항산화 효과를 나타내었다.As a result of the investigation of the antioxidative activity using the extract of the present invention, the extract of the Korean native had a strong antioxidative activity even in the case of the crude extract. Especially, the hexane and chloroform extract fractions showed an excellent antioxidative effect.
이외에도, 본 발명의 항산화 활성을 가지는 해당화 추출물은 기능성 식품 또는 식품 첨가제 그리고 기능성 음료 또는 음료 첨가제 등으로 사용될 수 있다.In addition, the extract having the antioxidative activity of the present invention can be used as a functional food or a food additive, a functional beverage or a beverage additive.
또한 본 발명은 마늘산(garlic acid)계 화합물로서 화학식 1의 베타그루코갈린 화합물을 항산화제로 사용하는 용도를 제공한다.The present invention also provides a use of a beta-glucogalline compound of formula (1) as an antioxidant as a garlic acid-based compound.
본 발명은 또한 상기 화합물을 해당화에서 분리·정제하는 방법을 제공한다. 본 발명은 충청남도 서해안에서 확보한 해당화(Rosa rugosa)를 각종 유기용매로 추출한 상기 해당화 추출물로부터 실리카겔 칼람 크로마토그라피, ODS 칼람 크로마토그라피, GPC 칼람 크로마토그라피를 수행하여 항산화 활성을 보이는 활성물질을 분리·정제한다.The present invention also provides a method for separating and purifying the above-mentioned compounds from the corresponding plants. The present invention relates to a method for separating and purifying an active substance exhibiting antioxidative activity by performing silica gel column chromatography, ODS column chromatography, and GPC column chromatography from the above extract obtained by extracting Rosa rugosa obtained from West Sea of Chungcheongnam-do with various organic solvents do.
구체적으로, 본 발명은 상기 해당화로부터 얻은 부탄올 분획을 실리카겔 칼람 크로마토그라피를 수행한다. 이때 전개용매로는 클로로포름 : 메탄올의 혼합용매를 사용한다. 이에 더하여 상기활성 분획을 ODS 칼람 크로마토그라피를 수행한다. 이때 전개용매로는 증류수와 메탄올을 사용한다. 상기 정제과정에서 확인된 활성분획으로 GPC 칼람 크로마토그라피를 수행한다. 이때 전개용매로는 클로로포름과 메탄올의 혼합용매를 사용한다.Specifically, in the present invention, the butanol fraction obtained from the above-mentioned compaction is subjected to silica gel column chromatography. As the developing solvent, a mixed solvent of chloroform and methanol is used. In addition, the active fraction is subjected to ODS column chromatography. Distilled water and methanol are used as the developing solvent. GPC column chromatography is performed on the active fractions identified in the purification process. As the developing solvent, a mixed solvent of chloroform and methanol is used.
본 발명은 상기 과정으로 분리·정제한 항산화 활성을 나타내는 활성 물질의화학적 구조를 질량분석 스펙트럼, 수소 및 탄소 핵자기 공명 스펙트럼 등의 방법으로 조사하여 이 화합물이 베타그루코갈린임을 확인하였다.In the present invention, the chemical structure of the active substance exhibiting antioxidative activity separated and purified by the above procedure was examined by mass spectrometry, hydrogen and carbon nuclear magnetic resonance spectroscopy, and it was confirmed that this compound was beta glucogalline.
본 발명은 상기 베타그루코갈린 화합물의 항산화 활성을 조사하기 위하여, 자유 래디칼(free radical)인 1,1-디페닐-2-피크릴하이드라질(1,1-diphenyl-2-picrylhydrazyl, DPPH)을 이용한 항산화 활성 측정방법(Choi, et al., Kor. J. Phamacogn, 24: 299-303, 1993)등 을 이용한다. 그 결과 본 발명의 베타그루코갈린 화합물은 천연 항산화제로 잘 알려진 토코페롤보다 약 1.4배 항산화 활성이 강한 것으로 나타나 항산화 활성에 탁월한 효과가 있음을 확인하였다(표 2 참조).In order to investigate the antioxidative activity of the beta glucogallgyline compound, 1,1-diphenyl-2-picrylhydrazyl (DPPH), which is a free radical, (Choi, et al., Kor. J. Phamacogn, 24: 299-303, 1993). As a result, it was confirmed that the beta-glucogalline compound of the present invention has an antioxidative activity about 1.4 times stronger than that of tocopherol, which is well known as a natural antioxidant, and has an excellent antioxidant activity (see Table 2).
이하 본 발명을 실시예에 의하여 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to examples.
하기 실시예는 본 발명을 구체적으로 예시하는 것이며, 본 발명의 내용이 실시예에 의해 한정되는 것은 아니다.The following examples illustrate the present invention in detail and are not intended to limit the scope of the present invention.
<실시예 1> 해당화 지상부의 용매분획의 제조≪ Example 1 > Production of solvent fraction in the above-mentioned ground part
충청남도 천리포 해변에서 채취한 해당화의 지상부를 대상으로 용매 분획하여 그의 항산화 활성을 조사하였다. 우선 건물중 270 g을 100% 메탄올 10 ℓ로 2회 추출하여 농축 건조시켜 메탄올 추출물 64 g을 얻었다.The antioxidative activities of the extracts from the seaweeds collected from Chungri beach in Chungcheongnam - do were investigated by solvent fractionation. First, 270 g of the extract was extracted twice with 10 L of 100% methanol, and then concentrated to dryness to obtain 64 g of a methanol extract.
상기 메탄올 추출물을 증류수 500 ml을 첨가한 다음 핵산 500 ml을 첨가하여 물층과 핵산층으로 3회 분획하였다. 물층에 클로로포름 500 ml를 첨가하여 클로로포름층과 물층으로 3회 용매분획하고, 물층에 다시 에칠아세테이트 500 ml를 첨가하여 에칠아세트층과 물층으로 3회 용매분획하고, 최종적으로 물층에 부탄올 500 ml를 첨가하여 부탄올층과 물층으로 3회 분획하였다.500 ml of distilled water was added to the methanol extract, and 500 ml of nucleic acid was added thereto. 500 ml of chloroform was added to the water layer, and the mixture was subjected to solvent fractionation three times with chloroform layer and water layer. 500 ml of ethyl acetate was further added to the water layer, and solvent fractionation was performed three times with an ethyl acetate layer and a water layer. Finally, 500 ml of butanol was added to the water layer And fractionated three times into a butanol layer and a water layer.
상기에서 얻은 각 분획을 감압 농축한 결과 핵산 분획, 클로로포름 분획, 에틸아세테이트 분획, 부탄올 분획 및 물 분획을 각각 4.3 g, 7 g, 8.3 g, 7 g, 37.4 g씩 얻을 수 있었다.Each of the fractions obtained above was concentrated under reduced pressure to obtain a nucleic acid fraction, chloroform fraction, ethyl acetate fraction, butanol fraction and water fraction of 4.3 g, 7 g, 8.3 g, 7 g and 37.4 g, respectively.
<실시예 2> 해당화 추출물의 항산화 활성 조사≪ Example 2 >
상기 실시예 1에서 얻은 각 분획의 항산화 활성을 자유 래디칼 (Free radical)인 1,1-디페닐-2-피크릴하이드라질(1,1-diphenyl-2-picrylhydrazyl, DPPH.)을 사용한 항산화 활성 측정법 (Choi, et al., Kor. J. Phamacogn, 24: 299-303, 1993)으로 그 조사하였다.The antioxidative activity of each fraction obtained in Example 1 was measured by using an antioxidative activity using 1,1-diphenyl-2-picrylhydrazyl (DPPH . ), Which is a free radical, (Choi, et al., Kor. J. Phamacogn, 24: 299-303, 1993).
시료 화합물을 농도별로 함유한 4 ml 메탄올을 유리 시험관에 넣은 다음 상기 DPPH (0. 15mM) 용액을 1 ml첨가하여 실온에서 30분간 반응시킨 후 517 nm에서 흡광도를 측정하였다. 이 때 RC50(μg)은 시료를 첨가하지 않은 대조구의 흡광도 값을 50% 감소시키는데 필요한 시료량(㎍)을 나타낸다.4 ml of methanol containing the sample compound in concentration was placed in a glass test tube, and 1 ml of the DPPH (0.15 mM) solution was added. After reacting at room temperature for 30 minutes, absorbance was measured at 517 nm. At this time, RC 50 (μg) represents the amount (μg) of sample required to reduce the absorbance value of the control without addition of the sample by 50%.
상기 표 1에 나타난 바와 같이 해당화 추출물은 조추출물인 상태에서도 강한 항산화 활성이 있고, 특히 헥산, 클로로포름 추출분획은 탁월한 항산화 효과를 보안다.As shown in the above Table 1, the extract of R. squid has a strong antioxidative activity even in the form of crude extract. Especially, the extract of hexane and chloroform has excellent antioxidative effect.
<실시예 3> 해당화의 지상부로부터 항산화물질의 분리 및 구조결정≪ Example 3 > Separation and structure determination of antioxidants from the above-ground part
실시예 1의 해당화의 지상부에서 얻은 용매 분획 중 항산화 활성이 강하면서 비교적 분리 정제가 용이한 부탄올 분획을 대상으로 하기의 과정에 따라 활성물질을 분리하였다.The active substance was isolated from the solvent fraction obtained from the above-mentioned ground of Example 1 in a butanol fraction having a strong antioxidative activity and relatively easy separation and purification, according to the following procedure.
실리카겔 (70-230 mesh, Merck사)을 클로로포름에 현탁시켜 충전시킨 유리 칼람 (5x70 cm)에 부탄올 분획(7 g)을 용출 분리하였다. 이때 용출 용매는 클로로포름 : 메탄올의 용매계를 이용하였으며, 항산화 활성을 나타내는 분획 5 g을 얻었다. 활성 분획의 일부 (2 g)을 ODS 겔 (70-230 mesh, YMC사)이 충진된 유리 칼람 (5x70 cm)을 이용하여 메탄올 : 증류수의 용매계로 용출시켜 활성 분획 1.1 g을 얻었다. 이를 다시 세파덱스(Sephadex) LH-20 겔 (100 g, Pharmacia사)로 충전된 유리 칼람을 이용하여 클로롤포롬 : 메탄올의 용매계로 용출시켜 활성 분획 35.7 mg을 단일물질로 얻었다.The butanol fraction (7 g) was eluted and separated on a glass column (5 x 70 cm) filled with silica gel (70-230 mesh, Merck) suspended in chloroform. At this time, a solvent system of chloroform: methanol was used as an eluting solvent, and 5 g of fraction showing antioxidative activity was obtained. A portion (2 g) of the active fraction was eluted with a solvent system of methanol: distilled water using a glass column (5 x 70 cm) packed with ODS gel (70-230 mesh, YMC) to obtain 1.1 g of the active fraction. This was eluted with a glass column packed with Sephadex LH-20 gel (100 g, Pharmacia) in chloroform: methanol to obtain 35.7 mg of the active fraction as a single substance.
분리한 화합물은 수소 핵자기 공명스펙트럼(도 2 참조)에 나타난 7.00 ppm의 시그날 (2H)과 탄소 핵자기 공명 스펙트럼(도 3 참조)의 108.9-145.5 ppm의 벤젠환 및 164.6 ppm의 케톤 유래의 시그날, 그리고 60.5-94.4 ppm에서 설탕(sugar) 유래의 6개의 시그날이 관찰되어 마늘산(garlic acid)에 당이 에스트(ester) 결합된 배당체 화합물로 추정되었다. 수소 핵자기 공명스펙트럼의 5.50 ppm에서 J=7.8 Hz의 아노머 양자(anomeric proton)의 시그날이 β-D-그루코스임을 시사해 주며, HMBC 스펙트럼에서 설탕의 1'와 아글리콘(aglycon) 3, 4위의 양자로부터 1위 케톤(ketone) 탄소에 각각 크로스 피크(cross peak)가 확인되어, 베타그루코갈린(β-glucogallin)으로 구조결정할 수 있었으며 문헌치(Saijo et al., Phytochemistry 29, 267, 1990)와 일치하였다.The separated compounds were identified by a signal (2H) of 7.00 ppm shown in the hydrogen nuclear magnetic resonance spectrum (see Fig. 2), a signal of benzene ring of 108.9-145.5 ppm of the carbon nuclear magnetic resonance spectrum (see Fig. 3) and a ketone of 164.6 ppm , And six signals from sugar at 60.5-94.4 ppm were observed to be glycoside compounds in which sugar was ester bonded to garlic acid. The signal of the anomeric proton at 5.50 ppm of J = 7.8 Hz of the hydrogen nuclear magnetic resonance spectrum is β-D-glucos, and in the HMBC spectrum, 1 'of sugar and aglycon 3, Cross peaks were observed in the first ketone carbon from the fourth protons and the structure was determined to be β-glucogallin. Saijo et al., Phytochemistry 29, 267 , 1990).
본 발명의 베타그루코갈린 화합물의 물리화학적 특성은 다음과 같다.The physico-chemical properties of the beta-glucogalline compound of the present invention are as follows.
(1) 일반명: 베타그루코갈린 (β-glucogallin)(1) Common name: beta-glucogallin
화학명: 베타-D-글로코피라노스 1-(3,4,5-트리하이드록시벤조에이트)Chemical name: Beta-D-Glucopyranos 1- (3,4,5-trihydroxybenzoate)
(β-D-glucopyranose 1-(3,4,5,-trihydroxybenzoate)(? -D-glucopyranose 1- (3,4,5-trihydroxybenzoate)
(2) 물질의 성상 : 황갈색 오일상(2) Appearance of substance: tan yellow oil phase
(3) 분자량 : 332(3) Molecular weight: 332
(4) 분자식 : C13H16O10 (4) Molecular formula: C 13 H 16 O 10
(5) 질량분석 스펙트럼 (FAB-MS, m/z):(5) Mass spectrum (FAB-MS, m / z):
도 1에 나타난 바와 같으며, 질량분석치([M+H]+)는 333이다.1, and the mass spectrometric value ([M + H] + ) is 333.
(6) 수소 핵자기 공명 스펙트럼:(6) Hydrogen nuclear magnetic resonance spectrum:
디메칠설폭사이드(DMSO)를 용매로 하고 테트라메칠실린(TMS)를 표준 물질로 하여 조사하였다. 그 결과는 도 2에 나타난 바와 같다.Dimethylsulfoxide (DMSO) was used as a solvent and tetramethylsilane (TMS) was used as a reference material. The results are shown in Fig.
(7) 탄소 핵자기 공명 스펙트럼:(7) Carbon Nuclear Magnetic Resonance Spectrum:
디메칠설폭사이드(DMSO)를 용매로 하고 테트라메칠실린(TMS)를 표준 물질로 하여 조사하였다. 그 결과는 도 3에 나타난 바와 같다.Dimethylsulfoxide (DMSO) was used as a solvent and tetramethylsilane (TMS) was used as a reference material. The results are shown in Fig.
(8) 용해성: 뜨거운 물과 디메칠설폭사이드에 잘 녹는다.(8) Solubility: It dissolves well in hot water and Dimethylsulfoxide.
(9) 화학구조식:(9) Chemical formula:
화학식 1Formula 1
따라서 해당화에 있어서 주요 항산화물질은 베타그루코갈린인 것으로 판명되었다. 해당화로부터 베타그루코갈린 화합물의 분리는 본 발명자들에 의해서 처음 이루어진 것이다.Thus, the main antioxidant in the plant was found to be beta glucogalline. The separation of the beta glucogallgine compounds from the corresponding plants was first carried out by the present inventors.
해당화 지상부에서 높은 항산화활성을 나타낸 에칠아세테이트 분획의 활성물질은 항산화물질로 알려진 이소큐에르시트린(isoquercitrin)으로 확인되었다.The active ingredient of the fructose acetate fraction, which showed high antioxidant activity in the aerial part of the plant, was identified as isoquercitrin, which is known as an antioxidant.
<실시예 4> 베타그루코갈린 화합물의 항산화 활성 조사Example 4: Antioxidant activity of beta glucogallin compound
베타그루코갈린 화합물의 항산화 활성을 상기 실시예 2의 방법으로 조사하였다. 이때 항산화 활성을 나타내는데 사용한 RC50(μg/ml)은 1,1-디페닐-2-피크릴하이드라질 (DPPH)을 기질로 사용하여, 대조구의 흡광도 값의 50% 감소 시키는데 필요한 시료량(μg)이다.The antioxidative activity of the beta-glucogalline compound was examined by the method of Example 2 above. RC 50 (μg / ml) used for the antioxidant activity was determined by measuring the amount (μg) of sample required for reducing the absorbance value of the control by 50% using 1,1-diphenyl-2-picrylhydrazide (DPPH) to be.
베타그루코갈린의 항산화활성은 합성 항산화제인 BHA보다 약 1.65배, 천연 항산화제로 잘 알려진 토코페롤보다는 약 1.41배 높았다. 따라서, 베타그루코갈린은 항산화제로 이용이 기대된다.The antioxidant activity of beta - glucogalline was about 1.65 times higher than that of BHA, which is a synthetic antioxidant, and about 1.41 times higher than that of tocopherol, a natural antioxidant. Therefore, beta-glucogallin is expected to be used as an antioxidant.
상기에서 살펴본 바와 같이, 본 발명의 해당화 추출물 및 베타그루코갈린 화합물은 탁월한 항산화 활성을 나타내므로 앞으로 식물에서 유래한 안전하고 효과적인 항산화제로 널리 활용될 수 있다.As described above, the extract of the present invention and the beta glucogallgyline compound exhibit excellent antioxidative activity and can be widely used as safe and effective antioxidants derived from plants in the future.
또한, 본 발명의 제조방법으로 얻어진 해당화 추출물은 의약품 뿐만 아니라 식품 분야에 널리 응용될 수 있다.In addition, the extracts obtained by the method of the present invention can be widely applied not only to medicines but also to foodstuffs.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970055018A KR100262296B1 (en) | 1997-10-25 | 1997-10-25 | Use of β-glucogallin as anti-oxidation agent and isolation process of β-glucogallin |
KR1019990060007A KR100262383B1 (en) | 1997-10-25 | 1999-12-21 | Beta-glucogallin compound having antioxidant activity and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970055018A KR100262296B1 (en) | 1997-10-25 | 1997-10-25 | Use of β-glucogallin as anti-oxidation agent and isolation process of β-glucogallin |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990060007A Division KR100262383B1 (en) | 1997-10-25 | 1999-12-21 | Beta-glucogallin compound having antioxidant activity and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19990033613A true KR19990033613A (en) | 1999-05-15 |
KR100262296B1 KR100262296B1 (en) | 2000-08-01 |
Family
ID=19523420
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970055018A KR100262296B1 (en) | 1997-10-25 | 1997-10-25 | Use of β-glucogallin as anti-oxidation agent and isolation process of β-glucogallin |
KR1019990060007A KR100262383B1 (en) | 1997-10-25 | 1999-12-21 | Beta-glucogallin compound having antioxidant activity and preparation method thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990060007A KR100262383B1 (en) | 1997-10-25 | 1999-12-21 | Beta-glucogallin compound having antioxidant activity and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR100262296B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100414393B1 (en) * | 2001-01-12 | 2004-01-07 | 강원도 고성군 | Manufacturing Method for Tea and Beverage Using Rosa rugosa Thunberg |
KR20200082315A (en) * | 2018-12-28 | 2020-07-08 | 주식회사 차메디텍 | Antioxidant composition containing a compound isolated from extract of Rosa rugosa Thumb |
KR102267195B1 (en) * | 2020-12-04 | 2021-06-22 | (주) 신아비티 | Skin improvement composition comprising the active substance isolated from the strain culture |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0665278A (en) * | 1992-08-25 | 1994-03-08 | Jiyumoku Chushutsu Seibun Riyou Gijutsu Kenkyu Kumiai | New flavonoid glycoside |
JPH06279303A (en) * | 1993-03-25 | 1994-10-04 | Nippon Flour Mills Co Ltd | Glucosyltransferase inhibitor |
-
1997
- 1997-10-25 KR KR1019970055018A patent/KR100262296B1/en not_active IP Right Cessation
-
1999
- 1999-12-21 KR KR1019990060007A patent/KR100262383B1/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100414393B1 (en) * | 2001-01-12 | 2004-01-07 | 강원도 고성군 | Manufacturing Method for Tea and Beverage Using Rosa rugosa Thunberg |
KR20200082315A (en) * | 2018-12-28 | 2020-07-08 | 주식회사 차메디텍 | Antioxidant composition containing a compound isolated from extract of Rosa rugosa Thumb |
KR102267195B1 (en) * | 2020-12-04 | 2021-06-22 | (주) 신아비티 | Skin improvement composition comprising the active substance isolated from the strain culture |
Also Published As
Publication number | Publication date |
---|---|
KR20000017666A (en) | 2000-03-25 |
KR100262383B1 (en) | 2000-07-15 |
KR100262296B1 (en) | 2000-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bahorun et al. | Antioxidant activities of Crataegus monogyna extracts | |
WO2007109804A2 (en) | Extracts and methods comprising cinnamon species | |
Juan-Badaturuge et al. | Antioxidant principles of Tanacetum vulgare L. aerial parts | |
KR20130128017A (en) | Method of producing proanthocyanid in oligomer | |
EP0315378A2 (en) | Manufacture of medicaments for treating viral skin infections | |
Emam et al. | Isolation and structure elucidation of antioxidant compounds from leaves of Laurus nobilis and Emex spinosus | |
US5928646A (en) | Process for extracting catechin polyphenols from potentillas, extract obtained and its use | |
Patel et al. | Evaluation of antioxidant activity, phenol and flavonoid contents of Momordica charantia Linn fruit | |
KR100486763B1 (en) | Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof | |
Vongsak et al. | Optimization of Maclura cochinchinensis extract as a cosmeceutical component for antioxidant and anti-tyrosinase activities | |
Nemudzivhadi et al. | Antioxidant and antibacterial properties of Ziziphus mucronata and Ricinus communis leaves extracts | |
KR100460133B1 (en) | Production Method of Catechin with High Antioxidative Activity from The Extracts of Rosa davurica Pall | |
KR100262296B1 (en) | Use of β-glucogallin as anti-oxidation agent and isolation process of β-glucogallin | |
KR100363112B1 (en) | Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants | |
Tenuta et al. | Iridoid-and flavonoid-enriched fractions of Cornus sanguinea and Cornus mas exert antioxidant and anti-inflammatory effects and inhibit key enzymes in the treatment of metabolic disorders | |
Asres et al. | Radical scavenging compounds from Ethiopian medicinal plants | |
KR100585486B1 (en) | Antioxidant composition containing extracts or compounds derived from rubus coreanus | |
KR100363111B1 (en) | Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants | |
EP0820761A2 (en) | Tanning cosmetics containing caesapinia sappan L. extract | |
WO2011038472A1 (en) | Standardized plant extract, method for preparing an extract from plants of the sclerolobium genus, cosmetic composition, pharmaceutical composition and use of said extract | |
Radjah et al. | Stage of development and solvent effects on Phytochemistry and antioxidant activity of three algerian plants | |
Asres et al. | Studies on the anti-inflammatory activity of extracts and compounds from the leaves of Melilotus elegans | |
WO1996040182A1 (en) | Identification of a potent antioxidant from aloe barbadensis | |
Torero | Antioxidant activity of Avicennia alba Blume,(1826) family Avicenniaceae, leaf extracts using DPPH assay | |
KR100757086B1 (en) | Antioxidative composition containing extract of Carthamus tinctorius sprout |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20040310 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |